$CUR Company News Neuralstem gets FDA okay for

New Post Public Reply Private Reply Replies (0) Message Board

Aug 11, 2014 at 12:28 PM

$CUR Company News

Neuralstem gets FDA okay for depression study 10:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 5:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 5:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 7:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 7:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 3:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 3:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 2:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 2:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 3:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 4:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 11:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 10:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 2:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 2:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 6:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 1:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 9:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 12:36 p.m. April 13, 2007 - Greg Presto

10-Q: NEURALSTEM, INC. 6:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 10:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 11:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 9:35 a.m. July 7, 2014 - Seeking Alpha
An Early Valuation Of Neuralstem's NSI-189 For MDD 9:34 a.m. June 26, 2014 - Seeking Alpha
BrainStorm Tackles Neurodegenerative Diseases With Novel Cell Therapy 1:44 p.m. June 12, 2014 - Seeking Alpha
Neuralstem NSI-189 Abstract Teases At Potential Greatness 9:14 a.m. May 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For July 19th 12:10 p.m. May 19, 2014 - TheStreet.com
A trader's look at Neuralstem 3:07 p.m. May 14, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:29 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
BrainStorm to start Phase 2 ALS trial 10:12 a.m. April 28, 2014 - Seeking Alpha
Interesting CUR Put And Call Options For June 21st 11:54 a.m. April 22, 2014 - TheStreet.com
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning 8:41 a.m. April 22, 2014 - Seeking Alpha
Stem cell trial for spinal cord injury to proceed 10:02 a.m. April 16, 2014 - Seeking Alpha
Aastrom: Mice Scared Me Away 10:51 a.m. March 26, 2014 - Seeking Alpha
Senators introduce regenerative medicine bill 1:40 p.m. March 14, 2014 - Seeking Alpha
Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS 10:30 a.m. March 11, 2014 - Seeking Alpha
Osiris Therapeutics: Poised For Another Breakout 2:07 a.m. March 11, 2014 - Seeking Alpha
Major stem cell discovery might not be so major 2:32 p.m. March 10, 2014 - Seeking Alpha
10-K: NEURALSTEM, INC. 6:30 a.m. March 10, 2014 - Edgar Online - (EDG = 10Q, 10K)

Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 9:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 9:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 9:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 9:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 9:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 11:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 9:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 9:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 1:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 9:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 9:15 a.m. April 16, 2014 - PR Newswire - PRF
Equities Updates on Top Gainers -- Research on E-Commerce China Dangdang, Neuralstem, Cytokinetics, and Nu Skin Enterprises 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Neuralstem Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference 9:15 a.m. April 7, 2014 - PR Newswire - PRF
Study Shows Neuralstem Cells Transplanted Into Brain Significantly Improve Post-Stroke Symptoms in Rats 9:15 a.m. March 28, 2014 - PR Newswire - PRF
Equities Recording New Highs: Generac Holding, Sempra Energy, Neuralstem, and Great Plains Energy 9:41 a.m. March 18, 2014 - PR Newswire - PRF
Final Results Of Neuralstem Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology 9:15 a.m. March 17, 2014 - PR Newswire - PRF
Breakthroughs on the Horizon for CTE and Other Neurodegenerative Diseases 1:22 p.m. March 13, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wolfbox Unveils High-Octane Gear at SEMA 2026

Revving Up with Wolfbox's New Offerings There's an electrifying hum in the air, buzz-fueled by Wolfbox's latest gear debut at the SEMA Show 2026 in Las Vegas. The booth is a treasure trove for anyone keen on amping up their vehicle tech, with Wolfbox laying bare everything from dazzling dash cams to adaptive trail lights. It's the kind of smorgasbord that'd make a...

ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

UFC Gym Expands, Opening Murfreesboro Location Soon

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Infinix Unveils Global Flagship Store in Bali

Innovating Retail: Infinix Takes a Bold Step Imagine stomping the well-trodden grounds of Bali and striking the jackpot of tech experiences. That's right, Infinix is making waves with its first global Flagship Concept Store. Unveiled on October 31st, this venture is a serious flex from the tech giant, and it's absolutely in no mood to play small. The Flagship Store: A Hub...

Chemours Faces Legal Woes: Investor Actions by Dec. 7

A Rough Road Ahead for Chemours Investors Well, folks, Chemours Company isn’t exactly living its best life right now. Following a tumble of 18.63% in its stock price after less-than-stellar second-quarter earnings, the legal hounds are circling the wagons. Investors who picked up shares between February 20, 2026, and August 4, 2026, might be feeling a bit sore right...

Nanchang Expo Showcases Future of Aviation and Space

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Potomac Edison Targets Virginia Grid Revamp by 2030

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

Atrium's Heart Therapies: ATR 1072's Promising Data

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Urenco's LEU+ Boosts Future Nuclear Reactor Options

Urenco's Leap Forward with LEU+ Well, look who’s shaking up the nuclear scene—Urenco USA, that’s who. They’ve just churned out their first cylinder of low-enriched uranium plus (LEU+) at the National Enrichment Facility in Eunice, New Mexico. This isn’t just any regular Tuesday of uranium talk; it marks a seismic shift for nuclear fuel options in the Western...